Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC vs GSK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC GSK PHARMA FDC/
GSK PHARMA
 
P/E (TTM) x 23.9 62.2 38.4% View Chart
P/BV x 3.5 18.9 18.5% View Chart
Dividend Yield % 0.0 1.6 -  

Financials

 FDC   GSK PHARMA
EQUITY SHARE DATA
    FDC
Mar-23
GSK PHARMA
Mar-23
FDC/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs3181,684 18.9%   
Low Rs2291,231 18.6%   
Sales per share (Unadj.) Rs107.5191.9 56.0%  
Earnings per share (Unadj.) Rs11.735.9 32.6%  
Cash flow per share (Unadj.) Rs14.039.8 35.3%  
Dividends per share (Unadj.) Rs032.00 0.0%  
Avg Dividend yield %02.2 0.0%  
Book value per share (Unadj.) Rs119.5102.9 116.1%  
Shares outstanding (eoy) m165.91169.41 97.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.57.6 33.5%   
Avg P/E ratio x23.440.6 57.6%  
P/CF ratio (eoy) x19.536.7 53.2%  
Price / Book Value ratio x2.314.2 16.2%  
Dividend payout %089.2 0.0%   
Avg Mkt Cap Rs m45,368246,858 18.4%   
No. of employees `000NANA-   
Total wages/salary Rs m3,9095,950 65.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m17,83832,517 54.9%  
Other income Rs m5121,007 50.9%   
Total revenues Rs m18,35033,524 54.7%   
Gross profit Rs m2,4968,033 31.1%  
Depreciation Rs m389658 59.2%   
Interest Rs m4118 225.6%   
Profit before tax Rs m2,5788,364 30.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6402,288 28.0%   
Profit after tax Rs m1,9386,076 31.9%  
Gross profit margin %14.024.7 56.6%  
Effective tax rate %24.827.4 90.7%   
Net profit margin %10.918.7 58.1%  
BALANCE SHEET DATA
Current assets Rs m14,43124,943 57.9%   
Current liabilities Rs m7,29613,264 55.0%   
Net working cap to sales %40.035.9 111.4%  
Current ratio x2.01.9 105.2%  
Inventory Days Days26597 272.3%  
Debtors Days Days251216 116.2%  
Net fixed assets Rs m17,3476,988 248.2%   
Share capital Rs m1661,694 9.8%   
"Free" reserves Rs m19,65515,735 124.9%   
Net worth Rs m19,82017,430 113.7%   
Long term debt Rs m60-   
Total assets Rs m31,79631,930 99.6%  
Interest coverage x64.1462.6 13.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.61.0 55.1%   
Return on assets %6.219.1 32.6%  
Return on equity %9.834.9 28.1%  
Return on capital %13.248.1 27.5%  
Exports to sales %00-   
Imports to sales %8.548.1 17.6%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m1,50915,630 9.7%   
Fx inflow Rs m3,2591,622 200.9%   
Fx outflow Rs m1,50915,630 9.7%   
Net fx Rs m1,749-14,008 -12.5%   
CASH FLOW
From Operations Rs m1,5494,842 32.0%  
From Investments Rs m1118,079 1.4%  
From Financial Activity Rs m-1,800-15,433 11.7%  
Net Cashflow Rs m-138-2,512 5.5%  

Share Holding

Indian Promoters % 69.7 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 10.2 11.6 88.0%  
FIIs % 2.4 2.9 82.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.3 25.0 121.4%  
Shareholders   55,341 114,663 48.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on FDC vs GSK Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

FDC vs GSK Pharma Share Price Performance

Period FDC GSK Pharma S&P BSE HEALTHCARE
1-Day 1.06% 3.26% 1.18%
1-Month -4.50% -9.77% -0.75%
1-Year 69.82% 52.63% 61.82%
3-Year CAGR 14.77% 10.89% 18.16%
5-Year CAGR 20.71% 8.44% 19.79%

* Compound Annual Growth Rate

Here are more details on the FDC share price and the GSK Pharma share price.

Moving on to shareholding structures...

The promoters of FDC hold a 69.7% stake in the company. In case of GSK Pharma the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of FDC and the shareholding pattern of GSK Pharma.

Finally, a word on dividends...

In the most recent financial year, FDC paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

GSK Pharma paid Rs 32.0, and its dividend payout ratio stood at 89.2%.

You may visit here to review the dividend history of FDC, and the dividend history of GSK Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.